Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 20, 2022 | SVP International | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,312 | -- | 10,312 | |
| Jul 17, 2019 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,361 | -- | 10,361 | |
| Jul 12, 2019 | EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,400 | -- | 37,704 | |
| Sep 12, 2017 | Director | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 10,471 | $18.09 | 48,817 | |
| Apr 21, 2016 | SVP and General Counsel | Form 4 | Open market or private sale of non-derivative or derivative security | 10,500 | $12.33 | 32,469 | |
| Aug 03, 2011 | SVP - Global Operations | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,500 | -- | 10,500 | |
| Aug 03, 2011 | SVP, GM - International | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,500 | -- | 10,500 | |
| Aug 03, 2011 | Interim CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,500 | -- | 10,500 | |
| Aug 03, 2011 | Interim CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,500 | -- | 10,500 | |
| Jul 19, 2023 | SVP/GM, VIT | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,588 | -- | 58,716 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.